Follow The Filings

BVS Bioventus Inc.

Health Care, filed as BIOVENTUS INC (COM CL A), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by BVS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BVS insider trades
  • None no insider bought on the open market
  • $312K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Michelle McMurry-Heath Director
    Sale
    $105K 12,000 shares at $8.79 21% of stake
    Traded Mar 11 Filed Mar 13
    ↗
  2. Guy P Nohra Director
    Sale
    $76K 10,000 shares at $7.57 7.9% of stake
    Traded Dec 4, 2025 Filed Dec 8, 2025
    ↗
  3. Michelle McMurry-Heath Director
    Sale
    $131K 17,701 shares at $7.42 24% of stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 24 option exercises and 14 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
8-K 7.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $512.34M $573.28M $568.09M
Gross profit $328.19M $388.23M $388.16M
Gross margin * 64.1% 67.7% 68.3%
Net income -$156.23M -$33.54M $22.73M
Net margin * -30.5% -5.9% 4.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $268M $275.61M $272.84M
Total non-current assets * $542.91M $452.35M $410.72M
Total assets $810.91M $727.96M $683.56M
Total current liabilities $175.5M $210.4M $160.38M
Total non-current liabilities * $414.3M $331.95M $294.73M
Total equity $173.59M $147.94M $184.1M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $15.34M $38.8M $74.67M
Cash from investing $15.81M $22.96M -$3.25M
Cash from financing -$26.65M -$54.58M -$62.14M
Net change in cash $5.13M $4.62M $9.66M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.